No significant strengths identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| NNNNAnbio Biotechnology Class A Ordinary Shares | 1.8B | 41.11 | 734.11 | 21.95% | 31.03% | 29.08% | 0.12% | |
| DXRDaxor Corporation | 69.94M | 13.88 | 126.18 | -93.84% | 401.5% | 9.78% | 0.04% | 0.02 |
| BDXBecton, Dickinson and Company | 57.41B | 201.52 | 34.57 | 8.23% | 7.68% | 6.61% | 4.65% | 0.76 |
| HOLXHologic, Inc. | 16.7B | 74.87 | 22.55 | -0% | 13.79% | 11.5% | 6.86% | 0.52 |
| GCTKGlucoTrack, Inc. | 3.31M | 3.64 | 0.06 | -389.1% | ||||
| QDELQuidelOrtho Corporation | 2.26B | 33.30 | -1.09 | -7.17% | -43.43% | -57.92% | 0.90 | |
| KMTSKESTRA MEDICAL TECHNOLOGIES, LTD. | 1.29B | 22.04 | -4.30 | 115.05% | -177.99% | -80.55% | 0.22 | |
| OSUROraSure Technologies, Inc. | 186.51M | 2.60 | -10 | -54.17% | -47.92% | -16.64% | 12.64% | 0.04 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 143.17K | 611.69K | 589.46K | 43.49K | 208K | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 1.4% | 3.27% | -0.04% | -0.93% | 3.78% | -1% | - | - | - | - |
| Cost of Goods Sold | 44.89K | 59.58K | 140.21K | 95.56K | 0 | 47K | 0 | 23K | 13K | 36K |
| COGS % of Revenue | 0.31% | 0.1% | 0.24% | 2.2% | - | - | - | - | - | - |
| Gross Profit | 98.28K | 552.11K | 449.25K | -52.08K | 208K | -47K | 0 | -23K | -13K | -36K |
| Gross Margin % | 0.69% | 0.9% | 0.76% | -1.2% | 1% | - | - | - | - | - |
| Gross Profit Growth % | 16.85% | 4.62% | -0.19% | -1.12% | 4.99% | -1.23% | 1% | - | 0.43% | -1.77% |
| Operating Expenses | 4.8M | 6.27M | 11.17M | 6.58M | -3.3M | 3.08M | 4.04M | 4.41M | 7.09M | 14.51M |
| OpEx % of Revenue | 33.52% | 10.25% | 18.94% | 151.35% | -15.86% | - | - | - | - | - |
| Selling, General & Admin | 2.46M | 3.31M | 7.85M | 3.48M | 2.06M | 1.58M | 2.12M | 2.46M | 2.4M | 5.03M |
| SG&A % of Revenue | 17.21% | 5.41% | 13.32% | 80.05% | 9.92% | - | - | - | - | - |
| Research & Development | 2.27M | 2.88M | 3.21M | 3.03M | 1.61M | 1.5M | 1.81M | 1.95M | 4.69M | 9.48M |
| R&D % of Revenue | 15.84% | 4.71% | 5.44% | 69.74% | 7.72% | - | - | - | - | - |
| Other Operating Expenses | -1.28M | 78.89K | 107.55K | 67.98K | -6.97M | 0 | 110K | 0 | 0 | 0 |
| Operating Income | 4.66M | 5.66M | 10.58M | 6.54M | 3.51M | -3.13M | -4.04M | -4.43M | -7.1M | -14.55M |
| Operating Margin % | 32.52% | 9.25% | 17.94% | 150.35% | 16.86% | - | - | - | - | - |
| Operating Income Growth % | 0.29% | 0.21% | 0.87% | -0.38% | -0.46% | -1.89% | -0.29% | -0.1% | -0.6% | -1.05% |
| EBITDA | 4.7M | 5.72M | 10.64M | 6.6M | 3.56M | -3.08M | -4M | -4.41M | -7.09M | -14.51M |
| EBITDA Margin % | 32.83% | 9.34% | 18.06% | 151.71% | 17.1% | - | - | - | - | - |
| EBITDA Growth % | 0.29% | 0.22% | 0.86% | -0.38% | -0.46% | -1.87% | -0.3% | -0.1% | -0.61% | -1.05% |
| D&A (Non-Cash Add-back) | 44.89K | 59.58K | 67.88K | 58.79K | 51K | 47K | 42K | 23K | 13K | 36K |
| EBIT | -5.83M | -5.39M | -10.3M | -6.7M | -3.51M | -2.7M | -3.98M | -4.43M | -7.1M | -22.01M |
| Net Interest Income | -12.68K | -15.59K | -27.43K | -17.36K | -10K | 98K | 26K | 8K | 7K | -583K |
| Interest Income | 2.52K | 629 | 0 | 0 | - | 98K | 26K | 11K | 7K | 0 |
| Interest Expense | 15.21K | 16.22K | 24.4K | 18.29K | 10K | 0 | 0 | 3K | 0 | 583K |
| Other Income/Expense | -1.19M | 246.1K | 247.04K | -176.82K | -7.02M | 436K | -27K | -3K | 7K | -8.05M |
| Pretax Income | -5.84M | -5.41M | -10.33M | -6.72M | -3.52M | -2.7M | -4.07M | -4.43M | -7.1M | -22.6M |
| Pretax Margin % | -40.81% | -8.84% | -17.52% | -154.42% | -16.9% | - | - | - | - | - |
| Income Tax | -1.27M | 16.22K | 24.4K | -13.24M | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -5.84M | -5.41M | -10.33M | -6.72M | -3.52M | -2.7M | -4.07M | -4.43M | -7.1M | -22.6M |
| Net Margin % | -40.81% | -8.84% | -17.52% | -154.42% | -16.9% | - | - | - | - | - |
| Net Income Growth % | -2.96% | 0.07% | -0.91% | 0.35% | 0.48% | 0.23% | -0.51% | -0.09% | -0.6% | -2.18% |
| Net Income (Continuing) | -5.84M | -5.41M | -10.33M | -6.72M | -3.52M | -2.7M | -4.07M | -4.43M | -7.1M | -22.6M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | -29.50 | -17.88 | -26.32 | -28.66 | -38.30 | 60.76 |
| EPS Growth % | - | - | - | - | - | 0.39% | -0.47% | -0.09% | -0.34% | 2.59% |
| EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | -29.50 | -17.88 | -26.32 | -28.66 | -38.30 | 60.76 |
| Diluted Shares Outstanding | 0 | 0 | 0 | 0 | 119.18K | 150.79K | 154.51K | 154.75K | 207.6K | 371.91K |
| Basic Shares Outstanding | 0 | 0 | 0 | 0 | 119K | 150K | 154K | 154K | 185K | 371.91K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.71M | 2.02M | 1.23M | 314.14K | 718K | 10.23M | 6.11M | 2.38M | 4.87M | 5.77M |
| Cash & Short-Term Investments | 608.7K | 148.84K | 53.78K | 97.08K | 419K | 9.82M | 6.06M | 2.31M | 4.49M | 5.62M |
| Cash Only | 608.7K | 148.84K | 53.78K | 97.08K | 419K | 9.82M | 6.06M | 2.31M | 4.49M | 5.62M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 18.45K | 92.06K | 121.78K | 22.78K | 70K | 66K | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 47.03 | 54.93 | 75.41 | 191.19 | 122.84 | - | - | - | - | - |
| Inventory | 816.22K | 1.42M | 957.35K | 171K | 184K | 284K | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 6.64K | 8.7K | 2.49K | 653.13 | - | 2.21K | - | - | - | - |
| Other Current Assets | 211.59K | 266.43K | 63.82K | 9.7K | 21.71K | 56K | 43K | 67K | 376K | 151K |
| Total Non-Current Assets | 420.5K | 443.45K | 441.88K | 374.04K | 378K | 377K | 160K | 59K | 37K | 164K |
| Property, Plant & Equipment | 220.46K | 240.45K | 216.75K | 149.78K | 321K | 315K | 109K | 40K | 27K | 154K |
| Fixed Asset Turnover | 0.65x | 2.54x | 2.72x | 0.29x | 0.65x | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 35.15K | 35.67K | 39.56K | 52.6K | 0 | 0 | 51K | 15K | 0 | 10K |
| Other Non-Current Assets | 164.88K | 167.33K | 185.57K | 171.66K | 57K | 62K | 0 | 4K | 10K | 0 |
| Total Assets | 2.13M | 2.46M | 1.67M | 688.19K | 1.1M | 10.61M | 6.26M | 2.44M | 4.91M | 5.93M |
| Asset Turnover | 0.07x | 0.25x | 0.35x | 0.06x | 0.19x | - | - | - | - | - |
| Asset Growth % | -0.66% | 0.15% | -0.32% | -0.59% | 0.59% | 8.68% | -0.41% | -0.61% | 1.01% | 0.21% |
| Total Current Liabilities | 1.51M | 2.35M | 3.69M | 3.22M | 2.27M | 1.34M | 883K | 1.01M | 1.51M | 1.27M |
| Accounts Payable | 1.08M | 1.63M | 2.42M | 2.06M | 1.53M | 869K | 631K | 672K | 839K | 992K |
| Days Payables Outstanding | 8.8K | 10.01K | 6.3K | 7.88K | - | 6.75K | - | 10.66K | 23.56K | 10.06K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 240.36K | 363.74K | 336.78K | 239.96K | 195K | 244K | 0 | 341K | 673K | 252K |
| Current Ratio | 1.13x | 0.86x | 0.33x | 0.10x | 0.32x | 7.61x | 6.91x | 2.35x | 3.22x | 4.52x |
| Quick Ratio | 0.59x | 0.25x | 0.07x | 0.04x | 0.24x | 7.39x | 6.91x | 2.35x | 3.22x | 4.52x |
| Cash Conversion Cycle | -2.12K | -1.26K | -3.73K | -7.04K | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.59M | 11.06M | 14.56M | 339.88K | 236K | 279K | 227K | 195K | 196K | 17.66M |
| Long-Term Debt | 160.31K | 162.03K | 182.77K | 168.22K | 191K | 197K | 210K | 195K | 196K | 203K |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 45K | 82K | 17K | 0 | 0 | 33K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 7.43M | 10.9M | 14.38M | 171.66K | 0 | 0 | 0 | 0 | 0 | 17.42M |
| Total Liabilities | 9.1M | 13.41M | 18.24M | 3.56M | 2.51M | 1.62M | 1.11M | 1.21M | 1.71M | 18.93M |
| Total Debt | 160.31K | 162.03K | 182.77K | 168.22K | 378K | 363K | 250K | 195K | 196K | 267K |
| Net Debt | -448.39K | 13.2K | 128.99K | 71.14K | -41K | -9.46M | -5.81M | -2.12M | -4.3M | -5.35M |
| Debt / Equity | - | - | - | - | - | 0.04x | 0.05x | 0.16x | 0.06x | - |
| Debt / EBITDA | 0.03x | 0.03x | 0.02x | 0.03x | 0.11x | - | - | - | - | - |
| Net Debt / EBITDA | -0.10x | 0.00x | 0.01x | 0.01x | -0.01x | - | - | - | - | - |
| Interest Coverage | 306.17x | 348.78x | 433.51x | 357.50x | 350.60x | - | - | -1477.33x | - | -24.95x |
| Total Equity | -6.97M | -10.95M | -16.57M | -2.87M | -1.41M | 8.98M | 5.16M | 1.23M | 3.2M | -13M |
| Equity Growth % | -0.44% | -0.57% | -0.51% | 0.83% | 0.51% | 7.36% | -0.43% | -0.76% | 1.6% | -5.07% |
| Book Value per Share | -1.23 | -1.82 | -2.43 | - | -11.85 | 59.57 | 33.36 | 7.95 | 15.40 | -34.95 |
| Total Shareholders' Equity | -6.97M | -10.95M | -16.57M | -2.87M | -1.41M | 8.98M | 5.16M | 1.23M | 3.2M | -13M |
| Common Stock | 5.69K | 6.03K | 6.82K | 141.64K | 162K | 15K | 15K | 15K | 20K | 1K |
| Retained Earnings | -29.38M | -35.6M | -47.37M | -87.19M | -90.7M | -93.4M | -97.47M | -101.9M | -109.85M | -132.45M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 90.17K | 62.58K | 110.67K | 164.23K | 124K | 15K | -6K | 17K | 64K | -8K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -4.57M | -5.31M | -5.9M | -4.89M | -3.9M | -3.5M | -3.77M | -3.73M | -6.56M | -12.49M |
| Operating CF Margin % | -31.89% | -8.68% | -10% | -112.5% | -18.75% | - | - | - | - | - |
| Operating CF Growth % | -0.36% | -0.16% | -0.11% | 0.17% | 0.2% | 0.1% | -0.08% | 0.01% | -0.76% | -0.9% |
| Net Income | -5.84M | -5.41M | -10.33M | -6.72M | -3.52M | -2.7M | -4.07M | -4.43M | -7.1M | -22.6M |
| Depreciation & Amortization | 44.89K | 59.58K | 67.88K | 58.79K | 50.59K | 47K | 42K | 23K | 13K | 36K |
| Stock-Based Compensation | 18.01K | 70.25K | 2.71M | 705.25K | 512.38K | 22K | 223K | 439K | 281K | 173K |
| Deferred Taxes | -149.09K | -78.55K | -300.32K | 0 | 0 | 0 | 42K | 0 | 0 | 0 |
| Other Non-Cash Items | 1.28M | -629 | 3.03K | -927 | 7.55K | 160K | 44K | 60K | 55K | 9.83M |
| Working Capital Changes | 81.3K | 47.25K | 1.96M | 1.06M | -953.47K | -1.03M | -53K | 184K | 190K | 67K |
| Change in Receivables | 4.13K | -73.44K | -19.27K | 89.31K | -44.04K | 10K | 68K | 0 | 0 | 0 |
| Change in Inventory | -737.55K | -590.62K | 608.21K | 720.38K | 953 | -85K | 293K | 0 | 0 | 0 |
| Change in Payables | 982.22K | 526.56K | 620.8K | -261.92K | -600.35K | -714K | -257K | 74K | 167K | 263K |
| Cash from Investing | -203.17K | -76.45K | -19.47K | -5.37K | -23.43K | -53K | -1K | 1K | 0 | -104K |
| Capital Expenditures | -143.74K | -76.45K | -19.47K | -5.37K | -23.43K | -53K | -5K | -1K | 0 | -104K |
| CapEx % of Revenue | 1% | 0.12% | 0.03% | 0.12% | 0.11% | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -59.43K | 0 | 0 | 0 | 0 | 0 | 4K | 2 | 0 | 0 |
| Cash from Financing | -460.86K | 4.94M | 5.75M | 4.96M | 4.2M | 13.01M | 0 | 0 | 8.73M | 13.74M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | -57.06K | -13.53K | -5.73K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 36.14K | 1.64M | 1.95M | 2.26M | 33K | 0 | 0 | 0 | 0 | 85K |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -4.71M | -5.39M | -5.91M | -4.9M | -3.92M | -3.55M | -3.77M | -3.73M | -6.56M | -12.59M |
| FCF Margin % | -32.89% | -8.81% | -10.03% | -112.62% | -18.86% | - | - | - | - | - |
| FCF Growth % | -0.37% | -0.14% | -0.1% | 0.17% | 0.2% | 0.09% | -0.06% | 0.01% | -0.76% | -0.92% |
| FCF per Share | -0.83 | -0.89 | -0.87 | - | -32.91 | -23.57 | -24.43 | -24.10 | -31.59 | -33.86 |
| FCF Conversion (FCF/Net Income) | 0.78x | 0.98x | 0.57x | 0.73x | 1.11x | 1.30x | 0.93x | 0.84x | 0.92x | 0.55x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | - | - | -71.23% | -57.54% | -138.92% | -320.62% | - |
| Gross Margin | 68.64% | 90.26% | 76.21% | -119.75% | 100% | - | - | - | - | - |
| Net Margin | -4080.67% | -884.39% | -1752.24% | -15442.01% | -1690.38% | - | - | - | - | - |
| Debt / Equity | - | - | - | - | - | 0.04x | 0.05x | 0.16x | 0.06x | - |
| Interest Coverage | 306.17x | 348.78x | 433.51x | 357.50x | 350.60x | - | - | -1477.33x | - | -24.95x |
| FCF Conversion | 0.78x | 0.98x | 0.57x | 0.73x | 1.11x | 1.30x | 0.93x | 0.84x | 0.92x | 0.55x |
| Revenue Growth | 139.51% | 327.26% | -3.63% | -92.62% | 378.29% | -100% | - | - | - | - |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|
| Europe | 32K | 13.42K | 431.77K | 504.19K | 41.49K | 208.46K |
| Europe Growth | - | -58.06% | 3117.38% | 16.77% | -91.77% | 402.46% |
| Asia and Pacific | - | 129.75K | 179.92K | 85.27K | 2K | 300 |
| Asia and Pacific Growth | - | - | 38.67% | -52.60% | -97.65% | -85.00% |
| Asia Pacific | 27.77K | - | - | - | - | - |
| Asia Pacific Growth | - | - | - | - | - | - |
GlucoTrack, Inc. (GCTK) has a price-to-earnings (P/E) ratio of 0.1x. This may indicate the stock is undervalued or faces growth challenges.
GlucoTrack, Inc. (GCTK) grew revenue by 0.0% over the past year. Growth has been modest.
GlucoTrack, Inc. (GCTK) reported a net loss of $26.8M for fiscal year 2024.
GlucoTrack, Inc. (GCTK) had negative free cash flow of $14.4M in fiscal year 2024, likely due to heavy capital investments.